Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2004
History of the development of azole derivativesJ A MaertensIdrugs : the Investigational Drugs Journal|September 13, 2005
Sch-27899 (Schering-Plough Corp)J A MaertensCurrent Opinion in Infectious Diseases|October 13, 2006
Antifungal prophylaxis in neutropeniaJ A Maertens, M A BoogaertsCurrent Pharmaceutical Design|January 19, 2000
Fungal cell wall inhibitors: emphasis on clinical aspectsJ A Maertens, M A BoogaertsActa Clinica Belgica|September 12, 2000
The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseasesR J Lories, J A Maertens, J L Ceuppens, et al.Journal of Clinical Microbiology|December 15, 2015
Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal FluidG M Chong, J A Maertens, K Lagrou, et al.Virulence|February 2, 2021
TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosisL Bernal-Martínez, S M Gonçalves, B de Andres, et al.The Journal of Antimicrobial Chemotherapy|August 24, 2018
Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxisE W Muilwijk, J A Maertens, W J F M van der Velden, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 1, 2019
Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosisL Pang, X Zhao, B L Dickens, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 13, 2010
Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohortJ W Hiemenz, I I Raad, J A Maertens, et al.Pageof 2